Dhampur Bio Organics Limited has completed the acquisition of 74% equity stake in DBION Private Limited (formerly known as Sonitron Chemicals Private Limited). The acquisition involved purchase of 7400 equity shares at face value of ₹10 per share, totaling ₹74,000.
This transaction represents 74% of the paid-up equity share capital of DBION Private Limited. The acquisition was executed in accordance with the Joint Venture Agreement entered into with Orgonew Private Limited.
Consequent to this acquisition, DBION Private Limited has become both a subsidiary of Dhampur Bio Organics Limited and a Joint Venture Company under the Joint Venture Agreement.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and references SEBI Master Circular No. HO/49/14/14(7)2025- CFD-POD2/l/3762/2026 dated January 30, 2026. This filing is in continuation to previous intimations dated April 20, 2026, May 30, 2026, and June 04, 2026 regarding the acquisition.
The document was signed by Ashu Rawat, Company Secretary & Compliance Officer, on July 09, 2026 at 20:39:12 IST.
#DhampurBioOrganics #M&A #SEBIDisclosure #RegulatoryCompliance #CorporateAction #Neutral